New cases tested for RR-/MDR-TB (%) in Bahrain
Bahrain: New cases tested for RR-/MDR-TB was 94.0% in 2024. ◆ Volatile
New cases tested for RR-/MDR-TB in Bahrain, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for new cases tested for rr-/mdr-tb in Bahrain is 94.0%, measured in 2024.
That represents a change of down 6.0% on the previous year and down 6.0% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Bahrain peaked at 100.0% in 2012 and was at its lowest, 2.0%, in 2005.
Bahrain ranks 76th of 192 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
New cases tested for RR-/MDR-TB in Bahrain, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 2.0% | — |
| 2006 | 2.0% | +0.0% |
| 2008 | 9.2% | +360.0% |
| 2009 | 15.0% | +63.0% |
| 2010 | 70.0% | +366.7% |
| 2011 | 99.0% | +41.4% |
| 2012 | 100.0% | +1.0% |
| 2013 | 100.0% | +0.0% |
| 2016 | 100.0% | +0.0% |
| 2017 | 100.0% | +0.0% |
| 2018 | 100.0% | +0.0% |
| 2019 | 92.0% | -8.0% |
| 2020 | 79.0% | -14.1% |
| 2021 | 94.0% | +19.0% |
| 2022 | 100.0% | +6.4% |
| 2023 | 100.0% | +0.0% |
| 2024 | 94.0% | -6.0% |
Bahrain compared with similar countries
- Bahrain's 94.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (64 countries reporting)
- Bahrain's 94.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 94.0%, 1.0× the median. (23 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in Bahrain changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2010 | +366.7% | 15.0% | 70.0% |
| 2008 | +360.0% | 2.0% | 9.2% |
| 2009 | +63.0% | 9.2% | 15.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.0% | 2.0% | 15.0% | 4 |
| 2010s | 95.1% | 70.0% | 100.0% | 8 |
| 2020s | 93.4% | 79.0% | 100.0% | 5 |
Countries ranked near Bahrain
More health data for Bahrain
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4635 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 476.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.6427 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0292 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2418 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Bahrain?
- New cases tested for rr-/mdr-tb in Bahrain was 94.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Bahrain?
- The highest recorded value was 100.0% in 2012.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Bahrain?
- The lowest recorded value was 2.0% in 2005.
- How does Bahrain rank for new cases tested for rr-/mdr-tb?
- Bahrain ranks 76th out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Bahrain?
- Over the last ten years it is down 6.0%. The long-run trend across the full record is volatile.
- Where does this Bahrain data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).